scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0272-6386(12)80997-8 |
P698 | PubMed publication ID | 8128936 |
P2093 | author name string | M Haas | |
P2860 | cites work | DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis | Q40687895 |
Membranous lupus nephropathy: a clinicopathologic study | Q44436019 | ||
Extramembranous glomerulonephritis in childhood: Relationship to systemic lupus erythematosus | Q45049211 | ||
Idiopathic membranous glomerulopathy preceding the emergence of systemic lupus erythematosus in two children | Q45177766 | ||
The clinical course of the proliferative and membranous forms of lupus nephritis. | Q47728168 | ||
The reaction of monomeric and aggregated immunoglobulins with C1. | Q47731630 | ||
Immunoglobulin classes and IgG subclasses of human antinuclear antibodies. A correlation of complement fixation and the nephritis of systemic lupus erythematosus. | Q53862657 | ||
Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification | Q67370394 | ||
Clinical and pathologic features of fibrillary glomerulonephritis | Q67977209 | ||
Pathologic differentiation between lupus and nonlupus membranous glomerulopathy | Q70302563 | ||
Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus | Q70749606 | ||
P433 | issue | 3 | |
P304 | page(s) | 358-364 | |
P577 | publication date | 1994-03-01 | |
P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
P1476 | title | IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies | |
P478 | volume | 23 |
Q39716942 | A Case of Membranous Glomerulonephropathy Associated with Takayasu's Arteritis. |
Q82093316 | A case of lymphangioleiomyomatosis with membranous nephropathy and likely systemic lupus |
Q39476063 | Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy |
Q73831623 | Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles |
Q37721290 | Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus |
Q33346920 | Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies |
Q80164828 | Chronic glomerulonephritis associated with IgG subclass deficiency |
Q40810605 | Circulating antibodies to α-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy |
Q64079848 | Complement Therapeutics in Autoimmune Disease |
Q85574653 | Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies |
Q36849177 | Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. |
Q36289545 | Glomerulonephritis, Th1 and Th2: what's new? |
Q38079058 | Idiopathic membranous nephropathy and IgG4: an interesting relationship |
Q36417907 | IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury |
Q85913681 | IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression |
Q43164390 | IgG subclasses and complement pathway in segmental and global membranous nephropathy. |
Q71974512 | IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis |
Q97067624 | IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production |
Q41087019 | Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases. |
Q77357899 | Intraglomerular monocyte infiltration and immune deposits in diffuse lupus glomerulonephritis |
Q43430971 | Lupus-like membranous nephropathy: Is it lupus or not? |
Q24652978 | M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy |
Q26740477 | Management of Membranous Nephropathy in Western Countries |
Q36009282 | Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases |
Q84344575 | Membranous glomerulonephritis in a patient with ankylosing spondylitis: a rare association |
Q37698191 | Membranous nephropathy: recent travels and new roads ahead |
Q44623298 | Membran�se Glomerulonephritis |
Q26775946 | Overview of IgG4-Related Tubulointerstitial Nephritis and Its Mimickers |
Q33843564 | P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation |
Q36706217 | Pathology and immunology of lupus glomerulonephritis: can we bridge the two? |
Q36029138 | Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy |
Q64260876 | Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential Diagnosis |
Q34052596 | Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein |
Q36953286 | Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. |
Q37929551 | Th subset balance in lupus nephritis |
Q38155652 | The role of complement in membranous nephropathy |
Search more.